Fabtech Technologies Cleanrooms Ltd

Fabtech Technologies Cleanrooms Ltd IPO

IPO Price Range: ₹80 - 85

We are engaged in the business of manufacturing and providing design-to-validation solutions of pre-engineered and pre-fabricated modular panels and doors for building cleanrooms for pharmaceutical, healthcare & biotech sectors. Our cleanroom solutions, which are tailor made as per our customers designs and global regulatory standards, comprises of wall panels, view panels, doors, risers, ceiling panels, covings, heat ventilation air conditioning (HVAC) system, epoxy flooring and electrification works. We provide a comprehensive service which includes initial design to validation, encompassing engineering, manufacturing, quality assurance, timely delivery, installation, commissioning, and validation and certification.

Min Investment

₹1,36,000

IPO Size

₹27 Cr

IPO Status

Live

Quantity in 1 Lot

1600

Max Bid allowed

1

Listing Exchange

BSE

IPO Application Timeline of Fabtech Technologies Cleanrooms Ltd

Open Date3 Jan 2025
Close Date7 Jan 2025
Allotment Date8 Jan 2025
Listing Date10 Jan 2025

IPO subscribed over

🚀 18.46x

This IPO has been subscribed by 33.9347x in retail and 0x in QIB.

Subscription Rate

Total Subscription18.46x
Retail Individual Investors33.9347x
Qualified Institutional Buyers0x
Non Institutional Investors13.5639x

Key Statistics

Bid Opening DateBid Opening Date3 Jan 2025
Bid Closing DateBid Closing Date7 Jan 2025
Allotment DateAllotment Date8 Jan 2025
Issue SizeIssue Size₹27.74Cr
Quantity in 1 lotQuantity in 1 lot1600

Strength and risks

Strength

Strength

  • Advanced manufacturing infrastructure and deep industry knowledge in cleanroom panels and HVAC systems.

  • Long term relationship with customers.

  • Support from larger group company.

  • Professional and experienced management team.

  • Diverse domain expertise with effective project integration capabilities.

  • Growing market opportunities and penetration in new industry segments.


Risk

Risk

  • The company has experienced negative cash flows in the prior periods.

  • The company has certain contingent liabilities which may adversely affect its financial condition.

  • Majority of its customers operate in the pharmaceuticals, healthcare and biotech sectors. Factors that adversely affect these sectors or capital expenditure by companies within these sectors may adversely affect its business, results of operations and financial condition.

  • The company requires certain approvals and licenses in the ordinary course of business. Any failures to successfully obtain/renew/update such registrations may adversely affect its operations, results of operations and financial condition.

  • The company propose to utilize a part of the Net Proceeds to undertake proposed acquisition of the equity shares of Kelvin Air Conditioning and Ventilation Systems Private Limited.

  • Its may in the future continue to make strategic acquisitions to grow the company business and further diversify product and service offerings. Its acquisitions are subject to various risks, including risks relating to the integration of these acquired businesses with its existing operations. An inability to identify, complete and successfully integrate such acquisitions could adversely affect its business prospects, results of operations and financial condition.

  • The company is dependent on limited number of suppliers for supply of key raw materials and the company has not made any long term supply arrangement with its suppliers. In an eventuality where its suppliers are unable to deliver it the required materials in a time-bound manner it may have a material adverse effect on the companys buusiness operations and profitability.

  • The Companys logo is not registered as on date of Red Herring Prospectus. Its may be unable toadequately protect the company intellectual property. Furthermore, its may be subject to claims alleging breach of third-party intellectual property rights.

  • The Net Proceeds from the Issue are proposed to be deployed by the Company to fund the consideration for the proposed acquisition. If the proposed acquisition is not completed, the proceeds of the Issue will be retained by the Company and used for other objects.

  • Its funding requirements and the proposed deployment of Net Proceeds are not appraised by any independent agency and deployment of funds raised through this Issue shall not be subject tomonitoring by any monitoring agency.

Promoters Holding

Investors Holdings %
Aasif Ahsan Khan55.59%
Aarif Ashan Khan13.77%
Hemant Mohan Anavkar11.47%
Manisha Hemant Anavkar11.47%
Naseem Ahsam Khan0.54%

About Fabtech Technologies Cleanrooms Ltd

OrganisationFabtech Technologies Cleanrooms Ltd
HeadquartersMumbai
IndustryMiscellaneous

Frequently Asked Questions

  • What is the size of the Fabtech Technologies Cleanrooms Ltd IPO?

    The size of the Fabtech Technologies Cleanrooms Ltd IPO is ₹27.74Cr .

  • What is 'pre-apply' for Fabtech Technologies Cleanrooms Ltd IPO?

    'Pre-apply' for Fabtech Technologies Cleanrooms Ltd IPO indicates your interest in the IPO before it opens for subscription. This ensures quick application when the IPO goes live.

  • When will my Fabtech Technologies Cleanrooms Ltd IPO order be placed?

    Your Fabtech Technologies Cleanrooms Ltd IPO order will be placed on 3 Jan 2025.

  • What are the open and close dates of the Fabtech Technologies Cleanrooms Ltd IPO?

    The open and close dates of the Fabtech Technologies Cleanrooms Ltd IPO are 3 Jan 2025 to 7 Jan 2025.

  • What is the lot size and minimum order quantity of the Fabtech Technologies Cleanrooms Ltd IPO?

    The lot size and minimum order quantity of the Fabtech Technologies Cleanrooms Ltd IPO are 1600 and 1600 respectively.

  • What would be the listing gains on the Fabtech Technologies Cleanrooms Ltd IPO?

    The potential listing gains on the Fabtech Technologies Cleanrooms Ltd IPO will depend on various market factors and cannot be predicted with certainty.